Junichi Kurogi
Overview
Explore the profile of Junichi Kurogi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagamatsu H, Sumie S, Niizeki T, Tajiri N, Iwamoto H, Aino H, et al.
Cancer Chemother Pharmacol
. 2016 Jan;
77(2):243-50.
PMID: 26754678
Purpose: Portal vein tumor thrombosis is a critical complication in patients with hepatocellular carcinoma (HCC). This prospective multicenter trial assessed the efficacy of hepatic arterial infusion chemoembolization therapy with cisplatin...
2.
Taguchi J, Shinozaki K, Baba S, Kurogi J, Nakane T, Kinoshita Y, et al.
Med Mol Morphol
. 2015 Apr;
49(1):34-41.
PMID: 25827661
Gastric endocrine cell carcinoma is a relatively rare tumor. We experienced a case of early gastric cancer in which an endocrine cell carcinoma was identified within a differentiated adenocarcinoma, and...
3.
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, et al.
Oncology
. 2012 Nov;
84(2):108-14.
PMID: 23147476
Background: Sorafenib, an oral multikinase inhibitor, was approved for the treatment of advanced hepatocellular carcinoma (HCC), but has not been adequately evaluated for safety and effectiveness in Japanese patients with...
4.
Niizeki T, Sumie S, Torimura T, Kurogi J, Kuromatsu R, Iwamoto H, et al.
J Gastroenterol
. 2012 Mar;
47(6):686-95.
PMID: 22382631
Background: Hepatic arterial infusion chemotherapy (HAIC) has been recognized as a useful therapeutic modality for patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to investigate the...
5.
Iwamoto H, Torimura T, Nakamura T, Hashimoto O, Inoue K, Kurogi J, et al.
Neoplasia
. 2011 Mar;
13(3):187-97.
PMID: 21390182
Background: Metronomic chemotherapy involves frequent, regular administration of cytotoxic drugs at nontoxic doses, usually without prolonged breaks. We investigated the therapeutic efficacies of metronomic S-1, an oral 5-fluorouracil prodrug, and...
6.
Nakano M, Ando E, Kuromatsu R, Torimura T, Sumie S, Takata A, et al.
Hepatol Res
. 2010 Oct;
40(10):989-96.
PMID: 20887334
Aim: This study explored recent improvements in the management of hepatocellular carcinoma (HCC) diagnosed during surveillance. Methods: The subjects were 1074 patients with HCC, subdivided into three groups. Group A...
7.
Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, et al.
Liver Int
. 2007 Sep;
27(8):1091-7.
PMID: 17845537
Background/aims: C-reactive protein (CRP) was recently identified as a prognostic factor for patients with hepatocellular carcinoma (HCC) after surgical resection. We investigated the relationship between the serum levels of high...
8.
Nagaoka S, Itano S, Nagamatsu H, Akiyoshi J, Kurogi J, Tajiri N, et al.
AJR Am J Roentgenol
. 2007 Feb;
188(3):652-8.
PMID: 17312050
Objective: The purpose of our study was to evaluate retrospectively the usefulness and complications associated with a temporary indwelling catheter system through the brachial artery for patients with liver tumors....
9.
Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, et al.
Liver Int
. 2006 Aug;
26(7):781-8.
PMID: 16911459
Background/aims: This study aimed to evaluate the usefulness of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (PET) and PET plus computed tomography (CT) fusion images for the detection of extrahepatic metastases of hepatocellular...
10.
Nagamatsu H, Itano S, Nagaoka S, Akiyoshi J, Matsugaki S, Kurogi J, et al.
Am J Gastroenterol
. 2004 Dec;
99(12):2369-75.
PMID: 15571585
Background And Aims: Exacerbation of liver damage during transhepatic arterial infusion chemotherapy (THAIC) is a critical complication in patients with hepatitis B virus (HBV) related hepatocellular carcinoma (HCC). We previously...